课题基金 / 基金详情

The cellular and molecular basis of age-dependent anemia: a single cell-based approach

The cellular and molecular basis of age-dependent anemia: a single cell-based approach
年龄依赖性贫血的细胞和分子基础:基于单细胞的方法
批准号:
BB/M024350/1
负责人:
Claus Nerlov
金额:
$57.24万
依托单位:
依托单位国家:
英国
项目类别:
Research Grant
财政年份:
2015
资助国家:
英国
项目状态:
已结题
起止时间:
2015 至 --

项目摘要

项目成果

Claus Nerlov的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
As we age our ability to produce the red blood cells that transport oxygen within the body declines, leading to increasing prevalence of anemia (i.e. low red cell mass) with age. This is accompanied by a higher risk of numerous infirmities associated with old age, including loss of mental capabilities, loss of mobility, as well as increased risk of hospitalization and of death associated with surgical procedures. While in some people the cause of the anemia can be identified as chronic inflammation or kidney dysfunction, about a third have no identifiable cause. In this project we will examine if changes to the hematopoietic stem cells (HSCs), the cells that produce all blood cell types, play a role in age-dependent anemia. We have developed a technique that allows us to measure the red cell production of a single HSC, and found that there are different types of HSCs with vastly different ability to make red blood cells. We now wish to examine if changes to the abundance of the different HSC subtypes can account for the decline in red cell production, and in addition, whether such changes are due to influences from the cells that surround and support the HSCs in the bone marrow.The aim of these studies is to identify mechanisms by which the decline in red cell production can be prevented, or ultimately reverted.
期刊论文(9)
专著(0)
科研奖励(0)
会议论文
DOI: 10.1038/ncomms11075
发表时间: 2016-03-24
期刊: Nature communications
影响因子: 16.6
作者: [Grover A, Sanjuan-Pla A, Thongjuea S, Carrelha J, Giustacchini A, Gambardella A, Macaulay I, Mancini E, Luis TC, Mead A, Jacobsen SE, Nerlov C]
通讯作者: Nerlov C
DOI: 10.1084/jem.20161418
发表时间: 2017-07-03
期刊: The Journal of experimental medicine
影响因子: --
作者: [Mead AJ, Neo WH, Barkas N, Matsuoka S, Giustacchini A, Facchini R, Thongjuea S, Jamieson L, Booth CAG, Fordham N, Di Genua C, Atkinson D, Chowdhury O, Repapi E, Gray N, Kharazi S, Clark SA, Bouriez T, Woll P, Suda T, Nerlov C, Jacobsen SEW]
通讯作者: Jacobsen SEW
DOI: 10.1038/ncb3346
发表时间: 2016-06
期刊: Nature cell biology
影响因子: 21.3
作者: [Pietras EM, Mirantes-Barbeito C, Fong S, Loeffler D, Kovtonyuk LV, Zhang S, Lakshminarasimhan R, Chin CP, Techner JM, Will B, Nerlov C, Steidl U, Manz MG, Schroeder T, Passegué E]
通讯作者: Passegué E
Hierarchical organization of haematopoietic stem- and progenitor cell populations during steady state and stress haematopoiesis
  • 批准号:
    MC_UU_00029/9
  • 项目类别:
    Intramural
  • 资助金额:
    $469.92万
  • 财政年份:
    2022
  • 负责人:
    Claus Nerlov
  • 依托单位:
Transcriptional and epigenetic mechanisms of HSC subtype diversification
  • 批准号:
    BB/V002198/1
  • 项目类别:
    Research Grant
  • 资助金额:
    $58.89万
  • 财政年份:
    2021
  • 负责人:
    Claus Nerlov
  • 依托单位:
Counteracting hematopoietic ageing by pharmacological inhibition of TGFbeta and IL-6 signaling
  • 批准号:
    MR/T015055/1
  • 项目类别:
    Research Grant
  • 资助金额:
    $56.29万
  • 财政年份:
    2020
  • 负责人:
    Claus Nerlov
  • 依托单位:
Cellular mechanisms of haematopoietic lineage commitment
  • 批准号:
    MC_UU_00016/7
  • 项目类别:
    Intramural
  • 资助金额:
    $257.13万
  • 财政年份:
    2017
  • 负责人:
    Claus Nerlov
  • 依托单位:
国内基金
海外基金
配子生成素GGN不同位点突变损伤分子伴侣BIP及HSP90B1功能导致精子形成障碍的发病机理
  • 批准号:
    82371616
  • 项目类别:
    面上项目
  • 资助金额:
    49.00万元
  • 批准年份:
    2023
  • 负责人:
    姚晨成
  • 依托单位:
MYRF/SLC7A11调控施万细胞铁死亡在三叉神经痛脱髓鞘病变中的作用和分子机制研究
  • 批准号:
    82370981
  • 项目类别:
    面上项目
  • 资助金额:
    48.00万元
  • 批准年份:
    2023
  • 负责人:
    陈敏洁
  • 依托单位:
PET/MR多模态分子影像在阿尔茨海默病炎症机制中的研究
  • 批准号:
    82372073
  • 项目类别:
    面上项目
  • 资助金额:
    48.00万元
  • 批准年份:
    2023
  • 负责人:
    张淼
  • 依托单位:
GREB1突变介导雌激素受体信号通路导致深部浸润型子宫内膜异位症的分子遗传机制研究
  • 批准号:
    82371652
  • 项目类别:
    面上项目
  • 资助金额:
    45.00万元
  • 批准年份:
    2023
  • 负责人:
    刘开江
  • 依托单位: